Skip to main content
Clinical Trials/NCT05975723
NCT05975723
Recruiting
Not Applicable

Effect of MIND Diet Intervention on Cognitive Function in Adults With Mild Cognitive Impairment

Zhejiang University1 site in 1 country240 target enrollmentJuly 26, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild Cognitive Impairment
Sponsor
Zhejiang University
Enrollment
240
Locations
1
Primary Endpoint
Change in Global Cognition measured by comprehensive Neuropsychological Test Battery (NTB)
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

To examine the effects of a 1-year cluster-randomized controlled intervention of MIND diet on cognitive function among 240 participants with mild cognitive function (MCI) aged 50 years and above from 4 communities.

Detailed Description

The current study is a 1-year cluster-randomized controlled intervention trial designed to examine whether the a localized modified Mediterranean-Dietary Approaches to Stop Hypertension (DASH) dietary intervention for neurodegenerative delay (MIND) diet will improve cognitive function among 240 participants with MCI from 4 communities. The modified MIND diet recommends 11 brain healthy food groups (green leafy vegetables, dark red and yellow vegetables, other vegetables, nuts, berries, beans, whole grains, seafood, poultry, olive/tea-seed oil and green tea) and limits intake of 4 unhealthy food groups (red meat and products, animal oil, pastries and sweets, and fried/fast food). This study will randomly assign 240 MCI participants to two groups: A) MIND diet intervention group and B) control group, and estimate the cognitive and biological impacts of the 1-year intervention.

Registry
clinicaltrials.gov
Start Date
July 26, 2023
End Date
August 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Zhejiang University
Responsible Party
Principal Investigator
Principal Investigator

Changzheng Yuan

Professor

Zhejiang University

Eligibility Criteria

Inclusion Criteria

  • At risk of cognitive decline: cognitive performance at the mean level or slightly lower than expected for age with no dementia (AD8\>=3 and/or 5-min MoCA \< 11)
  • Free of physical disabilities that preclude participation in the study
  • Willing to complete all study-related activities for 24 months
  • Willing to be randomized to either intervention group

Exclusion Criteria

  • Allergic to more than one type of food (nuts, berries, olive oil, or fish)
  • Diagnosed of dementia, severe diabetes mellitus, cardiovascular disease, cancer, thyroid disease, kidney disease, or liver disease
  • Diagnosed of major depression or other neuropsychological diseases
  • Severe loss of vision, hearing or communicative ability
  • Substance abuse within 6 months or heavy alcohol consumption (\> 2 drinks/day for women; \> 3 drinks/day for men).

Outcomes

Primary Outcomes

Change in Global Cognition measured by comprehensive Neuropsychological Test Battery (NTB)

Time Frame: Up to one year

Global cognitive performance (composite z-score) measured by comprehensive Neuropsychological Test Battery (NTB). The z-score calculation will use the population mean and standard deviation, and a higher z-score indicates better cognitive performance.

Change in Domain-specific Cognition

Time Frame: Up to one year

NTB domain-specific cognitive performance (composite z-score) for memory, executive function, attention, language, visuomotor speed and visuoconstruction. The z-score calculation will use the population mean and standard deviation, and a higher z-score indicates better cognitive performance.

Secondary Outcomes

  • Change in Alzheimer's Disease Cooperative Study Activities of Daily Living Mild Cognitive Impairment-Activities of Daily Living Inventory (ADCS MCI-ADL)(Up to one year)
  • Change in Clinical Dementia Rating-Sum of Boxes (CDR-SB)(Up to one year)
  • Change in Pittsburgh Sleep Quality Index (PSQI)(Up to one year)
  • Change in Montreal Cognitive Assessment (MoCA) score(Up to one year)

Study Sites (1)

Loading locations...

Similar Trials